Compile Data Set for Download or QSAR
Report error Found 8 Enz. Inhib. hit(s) with all data for entry = 11236
TargetMicrotubule-associated protein tau(Human)
Aprinoia Therapeutics

US Patent
LigandPNGBDBM601742(US11642413, Compound 159985)
Affinity DataKd:  100nMAssay Description:(A) Expression and Purification of Human Tau: 1 mM IPTG (Sangon Biotech, Cat. No A100487) was used to induce production of tau by bacteria (BL21, Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated protein tau(Human)
Aprinoia Therapeutics

US Patent
LigandPNGBDBM601749(US11642413, Compound 160219)
Affinity DataKd:  110nMAssay Description:(A) Expression and Purification of Human Tau: 1 mM IPTG (Sangon Biotech, Cat. No A100487) was used to induce production of tau by bacteria (BL21, Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated protein tau(Human)
Aprinoia Therapeutics

US Patent
LigandPNGBDBM601750(US11642413, Compound 160273)
Affinity DataKd:  470nMAssay Description:(A) Expression and Purification of Human Tau: 1 mM IPTG (Sangon Biotech, Cat. No A100487) was used to induce production of tau by bacteria (BL21, Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated protein tau(Human)
Aprinoia Therapeutics

US Patent
LigandPNGBDBM601751(US11642413, Compound 160313)
Affinity DataKd:  80nMAssay Description:(A) Expression and Purification of Human Tau: 1 mM IPTG (Sangon Biotech, Cat. No A100487) was used to induce production of tau by bacteria (BL21, Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated protein tau(Human)
Aprinoia Therapeutics

US Patent
LigandPNGBDBM601752(US11642413, Compound 160275)
Affinity DataKd:  230nMAssay Description:(A) Expression and Purification of Human Tau: 1 mM IPTG (Sangon Biotech, Cat. No A100487) was used to induce production of tau by bacteria (BL21, Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated protein tau(Human)
Aprinoia Therapeutics

US Patent
LigandPNGBDBM601753(US11642413, Compound 160383)
Affinity DataKd:  550nMAssay Description:(A) Expression and Purification of Human Tau: 1 mM IPTG (Sangon Biotech, Cat. No A100487) was used to induce production of tau by bacteria (BL21, Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated protein tau(Human)
Aprinoia Therapeutics

US Patent
LigandPNGBDBM601754(US11642413, Compound 160624)
Affinity DataKd:  120nMAssay Description:(A) Expression and Purification of Human Tau: 1 mM IPTG (Sangon Biotech, Cat. No A100487) was used to induce production of tau by bacteria (BL21, Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2023
Entry Details
Go to US Patent

TargetMicrotubule-associated protein tau(Human)
Aprinoia Therapeutics

US Patent
LigandPNGBDBM601755(US11642413, Compound 160744)
Affinity DataKd:  150nMAssay Description:(A) Expression and Purification of Human Tau: 1 mM IPTG (Sangon Biotech, Cat. No A100487) was used to induce production of tau by bacteria (BL21, Inv...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/11/2023
Entry Details
Go to US Patent